News
Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...
With weight-loss injections like Semaglutide gaining popularity, experts warn they’re not a one-size-fits-all fix. We got in touch with an expert who explains why long-term success lies in combining ...
54m
India Today on MSNEli Lilly's oral pill shows similar results to popular weight-loss drugsA new oral anti-diabetes pill, orforglipron, shows similar effectiveness to injectable GLP-1 drugs in a Phase 3 trial.
The mass rollout of weight loss jabs such as Mounjaro on the NHS in England will begin today as GPs are allowed to prescribe the drugs for the ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Presenting results from the REDEFINE 1 and REDEFINE 2 studies at the American Diabetes Association (ADA) congress in Chicago, Novo Nordisk pointed to a good tolerability profile for CagriSema and ...
Cancer patients must speak to their doctor before taking weight-loss jabs, a British charity has warned, amid a rise in people seeking help over whether they can take them.Macmillan Cancer Support ...
Mounjaro is an antidiabetic drug which has boomed in popularity because of how it works as an appetite suppressant. It’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results